DOCSLIB.ORG

Essays on the Emergence and Diffusion of Breakthroughs

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Essays on the Emergence and Diffusion of Breakthroughs Essays on the Emergence and Diffusion of Breakthroughs The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Chai, Sen. 2013. Essays on the Emergence and Diffusion of Breakthroughs. Doctoral dissertation, Harvard Business School. Citable link https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37367795 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Essays on the Emergence and Diffusion of Breakthroughs A dissertation presented by Sen Chai to the Technology and Operations Management Unit at the Harvard Business School in partial fulfillment of the requirements for the degree of Doctor of Business Administration in the subject of Technology and Operations Management Harvard University Cambridge, Massachusetts May 2013 Copyright © 2013 – Sen Chai All rights reserved Thesis advisor: Lee Fleming Sen Chai Essays on the Emergence and Diffusion of Breakthroughs Abstract This dissertation deals with the emergence and diffusion of creative breakthroughs. The first two chapters concentrate on breakthrough emergence to assess and expand extant theories of sources of breakthroughs, and employ a hybrid methodology. In particular, I study the discovery of RNA interference (RNAi) in the life sciences. By employing regressions, I find that the predictive power of current theories altogether is quite low: ranging from less than 1% for the Nobel Prize to 13% for productivity. These results prompted fieldwork and the use of interviews with scientist informants to address the gap and gain a deeper understanding of the phenomenon. My findings show that the seminal discovery was missed several times not only due to difficulties in solving a particular problem but also due to failures of identifying breakthrough opportunities and proposing them. I suggest a cognitive framework with institutional underpinnings at the basis of this failure stemming from three barriers: framing barriers, paradigmatic pressures and boundary barriers. In the problem identification stage, path dependence from established technologies and the quest toward normal science blinded scientists from recognizing a prospective breakthrough as they framed RNAi as a tool while ignoring its scientific merit for inquiry. In the problem-solving stage, scientists suffered from the socio-cognitive barrier of being constrained by current dogma. Due to reticence in challenging the dogma, they hesitated to propose solutions that significantly strayed away from the confines of established theory. Moreover, existing boundary barriers between communities of iii scientists intensified the effect of barriers in both stages. It prevented recognition of links between several prior instances of odd observations thus heightening the difficulty in identifying the breakthrough by misrepresenting the problem’s magnitude. While solving the problem, similar anti-dogmatic results stayed isolated and unsubstantiated which diminished confidence in proposing a radically new paradigm. The third chapter explores diffusion of discoveries beyond the boundary of the scientific institution. It focuses on academic-industry collaborations and assesses the effect of a mediated funding scheme on innovative performance – quantity, impact and collaborative nature of patents and papers – by comparing funded and unfunded firms. iv Table of Contents I. Introduction ................................................................................................................................... 1 II. Predicting Breakthroughs with Bibliometric Measures ............................................... 6 i. Introduction .................................................................................................................................................. 6 ii. Sources of Scientific and Technological Breakthroughs ............................................................ 8 iii. Methodology and Data ........................................................................................................................ 14 Setting .............................................................................................................................................. 14 Sampling and Identifying a Community of Scientists ................................................... 15 Regression Models ...................................................................................................................... 18 Dependent Variables .................................................................................................................. 19 Explanatory Variables ............................................................................................................... 20 iv. Results ........................................................................................................................................................ 24 Robustness Checks ...................................................................................................................... 33 Weaknesses and Limitations .................................................................................................. 43 v. Discussion .................................................................................................................................................. 44 vi. Conclusion ................................................................................................................................................ 49 III. Moving Beyond Bibliometrics ............................................................................................ 51 i. Introduction ............................................................................................................................................... 51 ii. Literature Review ................................................................................................................................... 54 Sources of Creativity and Breakthrough ............................................................................ 54 Emergence of Scientific and Technological Breakthroughs ...................................... 56 Science vs. Technology .............................................................................................................. 57 iii. Methods ..................................................................................................................................................... 58 Historical, Scientific and Technological Context of RNA Interference .................. 60 Data Collection .............................................................................................................................. 63 Data Analysis ................................................................................................................................. 68 iv. Findings ..................................................................................................................................................... 69 Problem Identification Failures ............................................................................................. 70 Problem-Solving Failures ......................................................................................................... 78 Success in the Discovery of the First RNAi Causal Trigger ......................................... 92 v. Implications to Bibliometric Literature from Remedial Practices ..................................... 93 Circumventing Framing Barriers .......................................................................................... 93 Circumventing Boundary Barriers ....................................................................................... 94 Circumventing Paradigmatic Pressures ............................................................................. 96 Bibliometric Operationalization ............................................................................................ 98 vi. Discussion .............................................................................................................................................. 103 vii. Conclusion.............................................................................................................................................. 107 IV. Fostering Translational Research .................................................................................. 109 i. Introduction ............................................................................................................................................ 109 ii. Theoretical Framework and Hypotheses .................................................................................. 112 iii. Methodology ......................................................................................................................................... 115 Setting ........................................................................................................................................... 116 Empirical Approach and Identification Strategy ......................................................... 119 iv. Results ..................................................................................................................................................... 127 Placebo Test on Period Prior to Funding Event ..........................................................
Load more

Recommended publications
  • USA Education Ph.D., Biology, Massachusetts Institute of Tech
    Victor R. Ambros, Ph.D. Silverman Professor of Natural Sciences Program in Molecular Medicine University of Massachusetts Medical School373 Plantation Street, Suite 306 Worcester, MA 01605 (508) 856-6380 [email protected] Personal Born: Hanover, NH, USA on December 1, 1953 Citizenship: USA Education Ph.D., Biology, Massachusetts Institute of Technology, Cambridge, MA 1976-1979 Thesis Title: The protein covalently linked to the 5' end of poliovirus RNA Advisor: Dr. David Baltimore B.S., Biology, Massachusetts Institute of Technology, Cambridge, MA 1971-1975 Professional Appointments Silverman Professor of Natural Sciences 2009-present Co-Director, RNA Therapeutics Institute 2009-2016 Professor, Program in Molecular Medicine 2008-present University of Massachusetts Medical School, Worcester, MA Professor of Genetics, Dartmouth Medical School 2001-2007 Professor, Biological Sciences, Dartmouth Medical School 1996-2001 Associate Professor, Biological Sciences, Dartmouth Medical School 1992-1996 Associate Professor, Department of Cellular and Development Biology, 1988-1992 Harvard University, Cambridge, MA Assistant Professor, Department of Cellular and Development Biology, 1985-1988 Harvard University, Cambridge, MA Postdoctoral Research 1979-1985 Supervisor: Dr. H. Robert Horvitz Massachusetts Institute of Technology, Cambridge, MA Graduate Research 1976-1979 Supervisor: Dr. David Baltimore Massachusetts Institute of Technology, Cambridge, MA Research Assistant 1975-1976 Supervisor: Dr. David Baltimore Center for Cancer Research,
    [Show full text]
  • Nature Medicine Essay
    COMMENTARY LASKER BASIC MEDICAL RESEARCH AWARD Of maize and men, or peas and people: case histories to justify plants and other model systems David Baulcombe One of the byproducts of molecular biology cork is altogether filled with air, and that air is has been support for the ‘model system’ con- perfectly enclosed in little boxes or cells distinct cept. All living organisms are based on the same from one another.”)2 (Fig. 1). Two hundred fifty genetic code, they have similar subcellular years later, Beijerinck discovered a contagium structures and they use homologous metabolic vivum fluidum in extracts of diseased tobacco pathways. So, mechanisms can be investigated plants that he later referred to as a virus3. using organisms other than those in which In contemporary science, a green alga— the knowledge will be exploited for practical Chlamydomonas reinhardtii—is a useful model benefit. Model systems are particularly use- in the analysis of kidney disease4. However, ful in the early discovery phase of a scientific in this article, I refer to the contribution of endeavor, and recent progress in biomedical plant biology to a family of mechanisms that I science has fully vindicated their use. Jacques refer to as RNA silencing. This topic has been Monod, for example, famously justified his reviewed comprehensively elsewhere5,6, so here work on a bacterial model system by stating I focus on personal experience and my view of that “what is true for Escherichia coli is also future potential from this work. true for elephants.” My fellow laureates, Victor Ambros and Gary Ruvkun, can defend the use The early history of RNA silencing in of the worm Caenorhabditis elegans as a good plants model system and so I will focus on plants.
    [Show full text]
  • Ethical Principles in Ethical Principles in Scientific Research Scientific Research and Publications
    Hacettepe University Institute of Oncology Library ETHICAL PRINCIPLES IN SCIENTIFIC LectureRESEARCH author AND PUBLICATIONSOnlineby © Emin Kansu,M.D.,FACP ESCMID ekansu@ada. net. tr Library Lecture author Onlineby © ESCMID HACETTEPE UNIVERSITY MEDICAL CENTER Library Lecture author Onlineby © ESCMID INSTITUTE OF ONCOLOGY - HACETTEPE UNIVERSITY Ankara PRESENTATION • UNIVERSITY and RESEARCHLibrary • ETHICS – DEFINITION • RESEARCH ETHICS • PUBLICATIONLecture ETHICS • SCIENTIFIC MISCONDUCTauthor • SCIENTIFIC FRAUD AND TYPES Onlineby • HOW TO PREVENT© UNETHICAL ISSUES • WHAT TO DO FOR SCIENTIFIC ESCMIDMISCONDUCTS Library Lecture author Onlineby © ESCMID IMPACT OF TURKISH SCIENTISTS 85 % University – Based 1.78% 0.2 % 19. 300 18th ‘ACADEMIA’ UNIVERSITY Library AN INSTITUTION PRODUCING and DISSEMINATING SCIENCE Lecture BASIC FUNCTIONS author Online-- EDUCATIONby © -- RESEARCH ESCMID - SERVICESERVICE UNIVERSITY Library • HAS TO BE OBJECTIVE • HAS TO BE HONESTLecture AND ETHICAL • HAS TO PERFORM THEauthor “STATE-OF-THE ART” • HAS TO PLAYOnline THEby “ROLE MODEL” , TO BE GENUINE AND ©DISCOVER THE “NEW” • HAS TO COMMUNICATE FREELY AND HONESTLY WITH ALL THE PARTIES INVOLVED IN ESCMIDPUBLIC WHY WE DO RESEARCH ? Library PRIMARY AIM - ORIGINAL CONTRIBUTIONS TO SCIENCE Lecture SECONDARY AIM author - TOOnline PRODUCEby A PAPER - ACADEMIC© PROMOTION - TO OBTAIN AN OUTSIDE SUPPORT ESCMID SCIENTIFIC RESEARCH Library A Practice aimed to contribute to knowledge or theoryLecture , performed in disciplined methodologyauthor and Onlineby systematic approach©
    [Show full text]
  • PIE-1 Sumoylation Promotes Germline Fates and Pirna-Dependent Silencing in C
    RESEARCH ARTICLE PIE-1 SUMOylation promotes germline fates and piRNA-dependent silencing in C. elegans Heesun Kim1†, Yue-He Ding1†, Shan Lu2, Mei-Qing Zuo2, Wendy Tan1, Darryl Conte Jr1, Meng-Qiu Dong2, Craig C Mello1,3* 1RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, United States; 2National Institute of Biological Sciences, Beijing, China; 3Howard Hughes Medical Institute, Chevy Chase, United States Abstract Germlines shape and balance heredity, integrating and regulating information from both parental and foreign sources. Insights into how germlines handle information have come from the study of factors that specify or maintain the germline fate. In early Caenorhabditis elegans embryos, the CCCH zinc finger protein PIE-1 localizes to the germline where it prevents somatic differentiation programs. Here, we show that PIE-1 also functions in the meiotic ovary where it becomes SUMOylated and engages the small ubiquitin-like modifier (SUMO)-conjugating machinery. Using whole-SUMO-proteome mass spectrometry, we identify HDAC SUMOylation as a target of PIE-1. Our analyses of genetic interactions between pie-1 and SUMO pathway mutants suggest that PIE-1 engages the SUMO machinery both to preserve the germline fate in the embryo and to promote Argonaute-mediated surveillance in the adult germline. *For correspondence: Introduction [email protected] During every life cycle, the eukaryotic germline orchestrates a remarkable set of informational tasks †These authors contributed that shape heredity and create variation necessary for the evolution of new species. One approach equally to this work for understanding the mechanisms that promote germline specification and function has been the identification of genes whose protein products localize exclusively to the germline and for which Competing interests: The loss-of-function mutations result in absent or non-functional germ cells and gametes (Seydoux and authors declare that no Braun, 2006).
    [Show full text]
  • Fire Departments of Pathology and Genetics, Stanford University School of Medicine, 300 Pasteur Drive, Room L235, Stanford, CA 94305-5324, USA
    GENE SILENCING BY DOUBLE STRANDED RNA Nobel Lecture, December 8, 2006 by Andrew Z. Fire Departments of Pathology and Genetics, Stanford University School of Medicine, 300 Pasteur Drive, Room L235, Stanford, CA 94305-5324, USA. I would like to thank the Nobel Assembly of the Karolinska Institutet for the opportunity to describe some recent work on RNA-triggered gene silencing. First a few disclaimers, however. Telling the full story of gene silencing would be a mammoth enterprise that would take me many years to write and would take you well into the night to read. So we’ll need to abbreviate the story more than a little. Second (and as you will see) we are only in the dawn of our knowledge; so consider the following to be primer... the best we could do as of December 8th, 2006. And third, please understand that the story that I am telling represents the work of several generations of biologists, chemists, and many shades in between. I’m pleased and proud that work from my labo- ratory has contributed to the field, and that this has led to my being chosen as one of the messengers to relay the story in this forum. At the same time, I hope that there will be no confusion of equating our modest contributions with those of the much grander RNAi enterprise. DOUBLE STRANDED RNA AS A BIOLOGICAL ALARM SIGNAL These disclaimers in hand, the story can now start with a biography of the first main character. Double stranded RNA is probably as old (or almost as old) as life on earth.
    [Show full text]
  • 2006 Nobel Laureates Hearing Committee On
    S. HRG. 110–1209 2006 NOBEL LAUREATES HEARING BEFORE THE SUBCOMMITTEE ON SCIENCE, TECHNOLOGY, AND INNOVATION OF THE COMMITTEE ON COMMERCE, SCIENCE, AND TRANSPORTATION UNITED STATES SENATE ONE HUNDRED TENTH CONGRESS FIRST SESSION MAY 2, 2007 Printed for the use of the Committee on Commerce, Science, and Transportation ( U.S. GOVERNMENT PRINTING OFFICE 79–907 PDF WASHINGTON : 2013 For sale by the Superintendent of Documents, U.S. Government Printing Office Internet: bookstore.gpo.gov Phone: toll free (866) 512–1800; DC area (202) 512–1800 Fax: (202) 512–2104 Mail: Stop IDCC, Washington, DC 20402–0001 VerDate Nov 24 2008 09:23 Mar 19, 2013 Jkt 075679 PO 00000 Frm 00001 Fmt 5011 Sfmt 5011 S:\GPO\DOCS\79907.TXT JACKIE SENATE COMMITTEE ON COMMERCE, SCIENCE, AND TRANSPORTATION ONE HUNDRED TENTH CONGRESS FIRST SESSION DANIEL K. INOUYE, Hawaii, Chairman JOHN D. ROCKEFELLER IV, West Virginia TED STEVENS, Alaska, Vice Chairman JOHN F. KERRY, Massachusetts JOHN MCCAIN, Arizona BYRON L. DORGAN, North Dakota TRENT LOTT, Mississippi BARBARA BOXER, California KAY BAILEY HUTCHISON, Texas BILL NELSON, Florida OLYMPIA J. SNOWE, Maine MARIA CANTWELL, Washington GORDON H. SMITH, Oregon FRANK R. LAUTENBERG, New Jersey JOHN ENSIGN, Nevada MARK PRYOR, Arkansas JOHN E. SUNUNU, New Hampshire THOMAS R. CARPER, Delaware JIM DEMINT, South Carolina CLAIRE MCCASKILL, Missouri DAVID VITTER, Louisiana AMY KLOBUCHAR, Minnesota JOHN THUNE, South Dakota MARGARET L. CUMMISKY, Democratic Staff Director and Chief Counsel LILA HARPER HELMS, Democratic Deputy Staff Director and Policy Director CHRISTINE D. KURTH, Republican Staff Director and General Counsel KENNETH R. NAHIGIAN, Republican Deputy Staff Director and Chief Counsel SUBCOMMITTEE ON SCIENCE, TECHNOLOGY, AND INNOVATION JOHN F.
    [Show full text]
  • Advanced Information on the Nobel Prize in Physiology Or Medicine 2006
    Advanced Information on The Nobel Prize in Physiology or Medicine 2006 RNA INTERFERENCE This year’s Nobel Prize in Physiology or Medicine is shared by Professor Andrew Z. Fire at Stanford University, California, USA, and Professor Craig C. Mello at the University of Massachusetts Medical School in Worcester, USA. They receive the prize for their discovery that double-stranded RNA trig- gers suppression of gene activity in a homology-dependent manner, a process named RNA interference (RNAi). Their discovery revealed a new mechanism for gene regulation, and the biochemical machinery involved plays a key role in many essential cellular processes. Double-stranded RNA synthesized within the cell can reduce or abolish gene activity by RNAi-like mechanisms. This control system for gene expression has proven to be important for both the development of an organism and the physiological functions of cells and tissues. Furthermore, RNAi protects against RNA virus infections, especially in plants and invertebrate animals, and secures genome stability by keeping mobile elements silent. Today, double-stranded RNA is used as a powerful tool to experimentally elucidate the function of essentially any gene in a cell. The discovery of RNAi has already had an immense impact on biomedical research and will most likely lead to novel medical applications in the future. Introduction The gene expression process is of fundamental importance for all living organisms. Most genes reside in the chromosomes located in the cell nucleus and express themselves via proteins synthesised in the cytoplasm. The genetic material was identifi ed as deoxyribonucleic acid (DNA) in 1944 (ref. 1) and the double-helical nature of DNA was revealed in 1953 (by Francis Crick, James Watson and Maurice Wilkins; Nobel Prize in Physiology or Medicine in 1962).
    [Show full text]
  • ILAE Historical Wall02.Indd 10 6/12/09 12:04:44 PM
    2000–2009 2001 2002 2003 2005 2006 2007 2008 Tim Hunt Robert Horvitz Sir Peter Mansfi eld Barry Marshall Craig Mello Oliver Smithies Luc Montagnier 2000 2000 2001 2002 2004 2005 2007 2008 Arvid Carlsson Eric Kandel Sir Paul Nurse John Sulston Richard Axel Robin Warren Mario Capecchi Harald zur Hauser Nobel Prizes 2000000 2001001 2002002 2003003 200404 2006006 2007007 2008008 Paul Greengard Leland Hartwell Sydney Brenner Paul Lauterbur Linda Buck Andrew Fire Sir Martin Evans Françoise Barré-Sinoussi in Medicine and Physiology 2000 1st Congress of the Latin American Region – in Santiago 2005 ILAE archives moved to Zurich to become publicly available 2000 Zonismide licensed for epilepsy in the US and indexed 2001 Epilepsia changes publishers – to Blackwell 2005 26th International Epilepsy Congress – 2001 Epilepsia introduces on–line submission and reviewing in Paris with 5060 delegates 2001 24th International Epilepsy Congress – in Buenos Aires 2005 Bangladesh, China, Costa Rica, Cyprus, Kazakhstan, Nicaragua, Pakistan, 2001 Launch of phase 2 of the Global Campaign Against Epilepsy Singapore and the United Arab Emirates join the ILAE in Geneva 2005 Epilepsy Atlas published under the auspices of the Global 2001 Albania, Armenia, Arzerbaijan, Estonia, Honduras, Jamaica, Campaign Against Epilepsy Kyrgyzstan, Iraq, Lebanon, Malta, Malaysia, Nepal , Paraguay, Philippines, Qatar, Senegal, Syria, South Korea and Zimbabwe 2006 1st regional vice–president is elected – from the Asian and join the ILAE, making a total of 81 chapters Oceanian Region
    [Show full text]
  • Spring/Summer 2005, Vol. 27 No. 3 the Magazine of the University Of
    Elected to National Academy of Sciences, p. 3 UMMS Professor Craig Mello spring/summer 2005, vol. 27 no. 3 Justice Served The Magazine of The University of Massachusetts Medical School The RNAi Revolution is Here. The Pivotal Pancreas Neural Pioneers Plus, the Economics of RNAi L., the plural of life The name of this magazine encompasses the lives of those who make up the UMMS community, for which it is published. They are students, faculty, staff, alumni, volunteers, benefactors and others who aspire to help this campus achieve national distinction in education, research and public service. University of Massachusetts Medical School The University of Massachusetts Medical School was created in 1962 by an act of the Massachusetts Legislature and today is comprised of three schools. Since accepting its first class in 1970, the School of Medicine has provided students with an accessible, comprehensive and personally rewarding medical education of the highest quality, one which optimally prepares them to excel as physicians. The Graduate School of Biomedical Sciences, opened in 1979, is a faculty-initiated PhD program that trains scientists in a specialty area with a broad background in the basic medical sciences, in preparation for conducting research with direct relevance to human disease. Opened in 1986, the Graduate School of Nursing, through its master’s, post master’s, doctoral degree and Graduate Entry Pathway programs, provides professional educa- tion and training for advanced practice nurses within three specialties: adult acute/critical care nurse practitioners, adult ambulatory/community care nurse practitioners and advanced practice nurse educators. Commonwealth Medicine Commonwealth Medicine is UMass Medical School’s innovative public service initiative, provid- ing expertise to public sector agencies so they may optimize their efficiency and effectiveness.
    [Show full text]
  • Craig C. Mello (1960- ) [1]
    Published on The Embryo Project Encyclopedia (https://embryo.asu.edu) Craig C. Mello (1960- ) [1] By: May, Catherine Keywords: Biography [2] DNA and RNA [3] Craig C. Mello is an American developmental biologist and Nobel Laureate, who helped discover RNA interference [4] (RNAi). Along with his colleague Andrew Fire [5], he developed gene knockouts using RNAi. In 2006 Mello won theN obel Prize in Physiology or Medicine [6] for his contribution to the discovery of RNAi. Mello also contributed to developmental biology, focusing on gene regulation [7], cell signaling, cleavage formation, germline determination [8], cell migration [9], cell fate differentiation [10], and morphogenesis. Mello was born in New Haven, Connecticut on 18 October 1960 to Sally Cameron and James Mello. During Mello’s childhood, the family relocated from Connecticut to Falls Church Virginia and then to Fairfax, Virginia, where Mello’s father became assistant director of the Smithsonian Museum of Natural History in Washington, DC. Mello recalled memories of the outdoors, camping, searching for fossils, watching wildlife, and hiking the Blue Ridge Mountains. Mello formed an affinity for science, later stating that science is the best way to approach the world because it asks questions and admits no absolutes. Mello attended Fairfax High School. In 1978 Mello attended Brown University [11] and in 1982 graduated with an undergraduate degree in biochemistry. For graduate school, Mello first attended University of Colorado [12] at Boulder where he studied the nematode worm C. elegans in David Hirsh’s lab and met Mike Krause [13], Jim Kramer [14], Ken Kemphues [15] and Jim Priess [16], who all collaborated with Mello.
    [Show full text]
  • Hope Funds for Cancer Research Press Release
    Hope Funds for Cancer Research Press Release 2019 Hope Funds Honoree William G. Kaelin to Receive Nobel Prize For Immediate Release Media Contact: John A. Wells 212-769-2170 [email protected] Newport, RI - October 7, 2019 - The Hope Funds for Cancer Research, dedicated to advancing innovative research for the most difficult-to-treat cancers, congratulates its 2019 Award of Excellence recipient William G. Kaelin, M.D., for being awarded the 2019 Nobel Prize in Physiology or Medicine for his work in the discovery of how cells sense and adapt to oxygen availability. The Nobel Committee stated that Dr. Kaelin, along with Sir Peter Radcliffe and Gregg Semenza, established the basis for our understanding of how oxygen levels affect cellular metabolism and physiological function. Their discoveries have also paved the way for promising new strategies to fight anemia, cancer and many other diseases. "A noted target resulting from these discoveries is HIF (hypoxia-inducible factor)," stated Leah Rush Cann, Hope Funds Trustees, "Applications for increased HIF-expression are to treat anemia. Cancers result from tumors having increased HIF-expression, so drugs that inhibit HIF-expression could have wide ranging impact in cancer treatment." "We at the Hope Funds for Cancer Research congratulate Dr. William G. Kaelin, Jr. for being named a recipient of the 2019 Nobel Prize in Physiology or Medicine," stated Lewis C. Cantley, Ph.D., Chairman of the Hope Funds Board of Trustees. The awards were announced earlier today in Stockholm. To view the Nobel release, Click Here About William G. Kaelin, M.D. Dr. Kaelin is the Sidney Farber Professor of Medicine, in the Department of Medicine at the Dana-Farber Cancer Institute and the Brigham and Women's Hospital, Harvard Medical School.
    [Show full text]
  • Nobel Prize Inspiration Initiative in PARTNERSHIP with Spain 2018
    Nobel Prize Inspiration Initiative IN PARTNERSHIP WITH Spain 2018 Dossier Nobel Prize Inspiration Initiative (NPII) es un programa global, diseñado para que los Premios Nobel puedan compartir su experiencia personal y su visión sobre la ciencia, inspirando a estudiantes y jóvenes investigadores CUENTA CON UN IMPORTANTE PANEL DE PREMIOS NOBEL Cada evento tiene una duración de 2 o 3 días ▪ Dr. Peter Agre ▪ Dr. Barry Marshall ▪ Dr. Bruce Beutler ▪ Dr. Craig Mello ▪ Dra. Elizabeth Blackburn ▪ Dr. Paul Nurse ▪ Dr. Michael Brown ▪ Dr. Oliver Smithies ▪ Dr. Martin Chalfie ▪ Dr. Françoise Barré-Sinoussi ▪ Dr. Peter Doherty ▪ Dr. Randy Schekman ▪ Dr. Joseph Goldstein ▪ Dr. Harold Varmus ▪ Dr. Tim Hunt ▪ Dr. Brian Kobilka ▪ Dr. Roger Kornberg LAS ACTIVIDADES SE ORGANIZAN EN TORNO A TOPICS QUE PERMITEN COMPARTIR SU VISIÓN SOBRE EL DESARROLLO DE CARRERAS INVESTIGADORAS Los eventos incluyen la celebración de ponencias, ✓ Advice for Young Scientists ✓ Inspiration and Aspiration mesas redondas, entrevistas, sesiones de preguntas ✓ Career Insights ✓ Life after the Nobel Prize y respuestas, paneles de debate, promoviendo ✓ Characteristics of a Scientist ✓ Mentorship especialmente interacciones informales con los ✓ Clinician Scientists ✓ Surprises and Setbacks científicos más jóvenes. ✓ Collaboration ✓ The Nature of Discovery ✓ Communicating Research ✓ Work-Life Balance Los Premios Nobel se reúnen con jóvenes de ✓ Early Life ✓ Your Views diferentes instituciones, universidades, centros de ✓ Getting Started investigación, etc. 2 Los diferentes formatos de
    [Show full text]